IMUNON, Inc. announced on July 15, 2025, that the Nasdaq Hearing Panel granted its request for an exception to complete its compliance plan, allowing the company to maintain its listing on the Nasdaq Stock Market. This decision followed a comprehensive review of IMUNON’s strategies to regain compliance.
The Nasdaq Hearing Panel confirmed that IMUNON had already achieved compliance with the Equity Rule through recent fundraising activities. The company is committed to implementing its compliance plan to ensure sustained adherence to the minimum shareholder equity requirement and to regain compliance with the minimum bid price requirement.
The Panel approved an exception tailored to the time needed for IMUNON to regain compliance, rather than the full 180-day period initially requested. This outcome reflects confidence in the company's executable plan and its dedication to maintaining its Nasdaq listing.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.